Key Insights

Highlights

Treatment Research

1 treatments under study, led by Bu Zhong Yi Qi Tang Zhi Xue Tang Chuan Xin Lian Kang Yan Pian Mod Tian Wang Bu Xin Dan

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 2/3 (1)

Trial Status

Terminated1

Clinical Trials (1)

Research Network

Common Treatments

  • Bu Zhong Yi Qi Tang Zhi Xue Tang Chuan Xin Lian Kang Yan Pian Mod Tian Wang Bu Xin Dan1

Active Sponsors

  • Hadassah Medical Organization1

Top Investigators

Activity Timeline